Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Syk Rabbit anti-Human, Polyclonal, Invitrogen™

Rabbit Polyclonal Antibody

Manufacturer:  Invitrogen PA528574

Catalog No. PIPA528574


Add to cart

Description

Description

PA5-28575 targets DAPP1 in IHC (P) and WB applications and shows reactivity with Human samples. The PA5-28575 immunogen is recombit fragment corresponding to a region within amino acids 1 and 280 of Human DAPP1.

This gene encodes a member of the family of non-receptor type Tyr protein kinases. This protein is widely expressed in hematopoietic cells and is involved in coupling activated immunoreceptors to downstream signaling events that mediate diverse cellular responses, including proliferation, differentiation, and phagocytosis. It is thought to be a modulator of epithelial cell growth and a potential tumour suppressor in human breast carcinomas. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Specifications

Specifications

SYK
Polyclonal
Unconjugated
SYK
Liquid
SYK
Recombit protein fragment corresponding to a region within amino acids 1 and 283 of Human SYK
Antigen affinity chromatography
RUO
Antibody
Polyclonal
Human
Immunohistochemistry (Paraffin), Western Blot
1.02 mg/mL
0.1M tris glycine with 10% glycerol and 0.01% thimerosal; pH 7
P43405
p72-Syk, tyrosine-protein kinase SYK
Rabbit
IgG
100 μL
-20° C, Avoid Freeze/Thaw Cycles
Primary
6850
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit